ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The role of Alzheimer's disease risk genes in endolysosomal pathways

Szabo, Marcell P.; Mishra, Swati; Knupp, Allison; Young, Jessica E.*
Neurobiology of Disease2022-1DOI: 10.1016/j.nbd.2021.105576
37被引1阅读
引用收藏
分享

摘要

There is ample pathological and biological evidence for endo-lysosomal dysfunction in Alzheimer's disease (AD) and emerging genetic studies repeatedly implicate endo-lysosomal genes as associated with increased AD risk. The endo-lysosomal network (ELN) is essential for all cell types of the central nervous system (CNS), yet each unique cell type utilizes cellular trafficking differently (see Fig. 1). Challenges ahead involve defining the role of AD associated genes in the functionality of the endo-lysosomal network (ELN) and understanding how this impacts the cellular dysfunction that occurs in AD. This is critical to the development of new therapeutics that will impact, and potentially reverse, early disease phenotypes. Here we review some early evidence of ELN dysfunction in AD pathogenesis and discuss the role of selected AD-associated risk genes in this pathway. In particular, we review genes that have been replicated in multiple genome-wide association studies(Andrews et al., 2020; Jansen et al., 2019; Kunkle et al., 2019; Lambert et al., 2013; Marioni et al., 2018) and reviewed in (Andrews et al., 2020) that have defined roles in the endo-lysosomal network. These genes include SORL1, an AD risk gene harboring both rare and common variants associated with AD risk and a role in trafficking cargo, including APP, through the ELN; BIN1, a regulator of clathrin-mediated endocytosis whose expression correlates with Tau pathology; CD2AP, an AD risk gene with roles in endosome morphology and recycling; PICALM, a clathrin-binding protein that mediates trafficking between the trans-Golgi network and endosomes; and Ephrin Receptors, a family of receptor tyrosine kinases with AD associations and interactions with other AD risk genes. Finally, we will discuss how human cellular models can elucidate cell-type specific differences in ELN dysfunction in AD and aid in therapeutic development.

学科与关键词

关键词
AD risk genesEndolysosomal networkHuman cellular model
相关
加载中…
  • Impairment of the autophagy-lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential
    Zhang, Wei; Xu, Chengchao; Sun, Jichao; Shen, Han-Ming*; Wang, Jigang*; Yang, Chuanbin*Acta Pharmaceutica Sinica B, 2022, 12(3): 1019-1040.被引 49
  • Transcriptomics in Alzheimer's Disease: Aspects and Challenges.
    Bagyinszky, Eva; Giau, Vo Van; An, SeongSoo AINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21(10).
  • Role of ABC Transporters in the Pathogenesis of Alzheimer's Disease
    Abuznait Alaa H; Kaddoumi Amal*ACS Chemical Neuroscience, 2012, 3(11): 820-831.被引 11
查看全部 →

发表信息

论文状态
公开发表
期刊
Neurobiology of Disease
发表日期
2022-01
卷期
第 162 卷
页码
105576
DOI
10.1016/j.nbd.2021.105576
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
NIH [R01AG062148, K01AG059841, T32AG052354]; National Institute on Aging [R01AG062148, T32AG052354] Funding Source: NIH RePORTER

作者

  • S

    Szabo, Marcell P. (第一作者)

  • M

    Mishra, Swati

查看全部 4 位作者收起作者
  • K

    Knupp, Allison

  • Y

    Young, Jessica E. (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417